Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Unraveling the pros and cons of interferon-gamma gene regulation
  2. Young, H. A.
  3. Immunity. 2006, MAY; 24(5): 506-507.
  1. 2.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 3.   Endocrine expression of the active form of TGF-beta 1 in the TGF-beta 1 null mice fails to ameliorate lethal phenotype
  2. Longenecker, G.; Thyagarajan, T.; Nagineni, C. N.; Flanders, K. C.; Factor, V.; Miller, G.; Ward, J. M.; Nalca, A.; Rangnekar, V. M.; Thorgeirsson, S.; Kulkarni, A. B.
  3. Cytokine. 2002 18(1): 43-50.
  1. 4.   Responsiveness to transforming growth factor-beta (TGF-beta)- mediated growth inhibition is a function of membrane-bound TGF- beta type II receptor in human breast cancer cells
  2. Lynch, M. A.; Petrel, T. A.; Song, H.; Knobloch, T. J.; Casto, B. C.; Ramljak, D.; Anderson, L. M.; DeGroff, V.; Stoner, G. D.; Brueggemeier, R. W.; Weghorst, C. M.
  3. Gene Expression. 2001 9(4-5): 157-171.
  1. 5.   Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: Potential physiological and clinical relevance
  2. Ruscetti, F. W.; Bartelmez, S. H.
  3. International Journal of Hematology. 2001 74(1): 18-25.
  1. 6.   Heterozygous inactivation of TGF-beta 1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras
  2. McKenna, I. M.; Ramakrishna, G.; Diwan, B. A.; Kang, Y.; Shiao, Y. H.; Wakefield, L. M.; Powell, D. A.; Anderson, L. M.; Jakowlew, S. B.
  3. Toxicology Letters. 2001 123(2-3): 151-158.
  1. 7.   Enhanced tumorigenesis and reduced transforming growth factor- beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta 1
  2. Kang, Y.; Mariano, J. M.; Angdisen, J.; Moody, T. W.; Diwan, B. A.; Wakefield, L. M.; Jakowlew, S. B.
  3. Molecular Carcinogenesis. 2000 29(2): 112-126.
  1. 8.   Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression
  2. Maroulakou, I. G.; Shibata, M. A.; Anver, M.; Jorcyk, C. L.; Liu, M. L.; Roche, N.; Roberts, A. B.; Tsarfaty, I.; Reseau, J.; Ward, J.; Green, J. E.
  3. Oncogene. 1999 18(39): 5435-5447.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel